SerenaGroup, Inc.
🇺🇸United States
Clinical Trial Evaluating a Hyaluronic Acid Matrix in the Treatment of Chronic Non-healing Diabetic Foot Ulcers (DFUs)
Not Applicable
Not yet recruiting
- Conditions
- Diabetic Foot
- Interventions
- Device: Hēlaquis Matrix is a hyaluronic acid matrix (HaM)
- First Posted Date
- 2022-01-20
- Last Posted Date
- 2023-04-26
- Lead Sponsor
- SerenaGroup, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT05198544
Comparing a Synergistic Antimicrobial Cleanser and Gel to Normal Saline and an Amorphous Gel in Reducing Bioburden and Promoting Healing in Chronic Lower Extremity Ulcers
Not Applicable
Active, not recruiting
- Conditions
- Wound of Skin
- Interventions
- Device: BIAKOS™ Antimicrobial Skin & Wound Cleanser, BIAKŌS Antimicrobial Wound GelDevice: Normal Saline and Amorphous gel
- First Posted Date
- 2021-11-04
- Last Posted Date
- 2023-04-26
- Lead Sponsor
- SerenaGroup, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT05107050
- Locations
- 🇺🇸
The Serens Group Austin Research Center, Austin, Texas, United States
A Prospective Clinical Study Evaluating the Harvesting of Micografts
Not Applicable
Completed
- Conditions
- Chronic Wound
- Interventions
- Device: Autologous Regeneration of Tissue (ARTTM) system
- First Posted Date
- 2021-10-13
- Last Posted Date
- 2022-03-14
- Lead Sponsor
- SerenaGroup, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT05076578
- Locations
- 🇺🇸
SerenaGroup - Monroeville, Monroeville, Pennsylvania, United States
A Multicentre Prospective Study Evaluating an Off-loading Mattress Overlay System in Healing of Stage 3 Pressure Ulcers
Not Applicable
Recruiting
- Conditions
- Pressure Ulcer
- Interventions
- Device: Dabir Mattress Overlay System
- First Posted Date
- 2021-09-02
- Last Posted Date
- 2022-11-04
- Lead Sponsor
- SerenaGroup, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT05033470
- Locations
- 🇺🇸
SunnyView, Butler, Pennsylvania, United States
A Comparison Between Two Post-operative Dressings
Not Applicable
Completed
- Conditions
- Surgical Incision
- Interventions
- Device: DrySee® dressing with moisture detectionDevice: Tegaderm® + Pad transparent film dressing
- First Posted Date
- 2021-05-17
- Last Posted Date
- 2022-03-14
- Lead Sponsor
- SerenaGroup, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04888624
- Locations
- 🇺🇸
Serena Group Monroeville, Monroeville, Pennsylvania, United States
Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)
Phase 4
Recruiting
- Conditions
- Chronic Diabetic Foot Ulcers
- Interventions
- Biological: Dual Layer Amniotic Membrane (DLAM). Artacent®
- First Posted Date
- 2020-07-07
- Last Posted Date
- 2022-11-04
- Lead Sponsor
- SerenaGroup, Inc.
- Target Recruit Count
- 124
- Registration Number
- NCT04457752
- Locations
- 🇺🇸
New Hope Podiatry, Los Angeles, California, United States
🇵🇷Clinical Research Management Group, Coto Laurel, Puerto Rico
🇺🇸Royal Research, Pembroke Pines, Florida, United States
Compassionate Use of Hyperbaric Oxygen Therapy
- Conditions
- COVID-19
- First Posted Date
- 2020-05-13
- Last Posted Date
- 2020-10-23
- Lead Sponsor
- SerenaGroup, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT04386265
- Locations
- 🇺🇸
CHI, Chattanooga, Tennessee, United States
🇺🇸Providence Medical Wound Care Center, Kansas City, Kansas, United States
🇺🇸Innovative Healing Systems, Tampa, Florida, United States
The Effectiveness of a Mechanical Debridement Instrument in Reducing Bioburden in Chronic Wounds
Completed
- Conditions
- Chronic WoundsAcute Wounds
- First Posted Date
- 2020-04-13
- Last Posted Date
- 2021-03-18
- Lead Sponsor
- SerenaGroup, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT04342767
- Locations
- 🇺🇸
Serena Group Research Institute, Pittsburgh, Pennsylvania, United States
Evaluating Remote Ischemic Conditioning (RIC) and Standard of Care vs. Sham Therapy and Standard Care
Not Applicable
Withdrawn
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Device: Remote Ischemic Conditioning (RIC) Treatment
- First Posted Date
- 2020-04-02
- Last Posted Date
- 2021-02-15
- Lead Sponsor
- SerenaGroup, Inc.
- Registration Number
- NCT04332003
Randomized Double-Blind Controlled Clinical Trial
Not Applicable
Completed
- Conditions
- Acute WoundsChronic Wounds
- Interventions
- Other: NSSDevice: AnaSept®
- First Posted Date
- 2020-03-25
- Last Posted Date
- 2022-03-14
- Lead Sponsor
- SerenaGroup, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT04320628
- Locations
- 🇺🇸
Serena Group Research Institute, Pittsburgh, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath